| Sage unveils the Financial Symphony – a musical composition that reveals the hidden rhythms of business |
Globe Newswire |
09/29 |
05:46 |
| AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection |
Globe Newswire |
09/29 |
02:07 |
| Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer |
Globe Newswire |
09/25 |
02:00 |
| BREAKING: MLMC: Mike Lindell Media Corp., LindellTV, and Real America’s Voice Deliver Dual On‑Site Coverage at the White House and Joint Base Andrews for President Xi’s Arrival After Legacy Networks Declined Pool Coverage |
Globe Newswire |
09/24 |
11:17 |
| Yooz Expands Procede Integration With Payment Remittance and Warranty Invoice Capabilities |
Globe Newswire |
09/21 |
09:15 |
| Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day |
Globe Newswire |
09/21 |
07:00 |
| TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
09/20 |
00:21 |
| Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial |
Globe Newswire |
09/16 |
11:00 |
| New Report Says Finance Teams Are Speeding Up Tasks with AI, But Failing to Fix The Cash Cycle |
Globe Newswire |
09/16 |
08:00 |
| Wyebot Introduces Roam Doctor™ - Advanced Roaming Intelligence, Powered by Intel® Connectivity Analytics, for Deeper Wi-Fi Visibility |
Globe Newswire |
09/15 |
08:00 |
| Unilabs Advances Digital Pathology Across Europe with Proscia, Shaping the Future of Precision Medicine |
Globe Newswire |
09/14 |
02:00 |
| Report About the 1993 WWE Survivor Series Published by Pardu Productions |
Globe Newswire |
09/13 |
22:34 |
| AP Collective Awarded Best Crypto Marketing Agency for the Third Time in 2026 |
Globe Newswire |
09/11 |
13:05 |
| Atlantic HPC Group Inc. Seeks to Become Publicly Listed Through Business Combination with Aperture AC |
Globe Newswire |
09/11 |
07:00 |
| Amogy and LOTTE Fine Chemical Sign MOU to Advance Green Ammonia-to-Hydrogen and Ammonia-to-Power Solutions in South Korea |
Globe Newswire |
09/10 |
08:00 |
| Meridian launches Categorization Agent to power accurate accrual-basis books in the automated close |
Globe Newswire |
09/09 |
12:00 |
| Cumulus Media’s Westwood One, Official Network Audio Partner of the NFL, Celebrates 40th Consecutive Season and Reveals 2026 NFL Lineup and Programming Highlights, from NFL Kickoff to Super Bowl LXI |
Globe Newswire |
09/09 |
08:50 |
| Rezera Announces Ruvonoflast Met its Primary Inflammation Endpoint and Demonstrated Favorable Safety Profile in RESOLVE-1 Phase 2 Clinical Trial |
Globe Newswire |
09/09 |
08:01 |
| NodThera Inc. Changes Name to Rezera Inc. and Announces Ruvonoflast Phase 3 Development Program |
Globe Newswire |
09/09 |
08:00 |
| GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology |
Globe Newswire |
09/09 |
01:30 |
| CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026 |
Globe Newswire |
09/08 |
16:05 |
| The News Forum to Exclusively Air Education Reform: Lessons from England Documentary |
Globe Newswire |
09/03 |
15:33 |
| Ascentage Pharma to Participate in Four Upcoming Investor Conferences |
Globe Newswire |
09/02 |
08:00 |
| Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) |
Globe Newswire |
09/02 |
07:00 |
| AI Sports Betting Analytics App Stat Sniper Expands to 16 Leagues, Adding College Football Predictions and Europe’s Big Five Soccer Leagues |
Globe Newswire |
09/01 |
11:14 |
